Oct 26 (Reuters) – NextCell Pharma AB: * REPORTS ENCOURAGING NUMERICAL RESULTS IN YOUNGER CHILDREN – STRATEGY FOR ADULTS REMAINS UNCHANGED * CHILDREN AGED 7-11 TREATED WITH NXTCL-T1D PRESERVED MORE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
London (PA Media/dpa) - Pancreatic cancer is one of the most deadliest forms of cancer, yet…
Oct 26 (Reuters) - DWS GROUP GMBH & CO KGAA: * DEUTSCHE BANK AND DWS…
By Makiko Yamazaki and Kentaro Sugiyama TOKYO, Oct 26 (Reuters) - Japan's top automobile industry…
Oct 26 (Reuters) - British technology services provider Computacenter on Monday forecast annual profit above…
Kolon Global Corp: * KOLON GLOBAL: WINS 97.4 BILLION WON ORDER Source text: Further company…
VIDEO SHOWS: DAY ONE OF THE PAN PACIFIC OPEN - A WTA 500 TOURNAMENT IN…